Together with recent evidences showing that some key-glycolytic enzymes, such as GAPDH and PKM were able to regulate the translation of mRNAs in human T-cells and mouse embryonic stem cells, respectively [20,21], we explored the role of HK2 as an RBP regulating mRNA translation in human cancer cells. This evidence concerns the gene HK2 and cancer.